Forough Rasoulian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Forough Rasoulian has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abolfazl Heydari
Polymer Institute of the Slovak Academy of Sciences, Dúbravská cesta 9, 845 41, Bratislava, Slovakia
4 shared publications Martin Klein
3 shared publications- Stefan Nehrer
Center for Regenerative Medicine, University for Continuing Education Krems, 3500 Krems, Austria
3 shared publications - Alexander Otahal
Center for Regenerative Medicine, Department for Health Sciences, Medicine and Research, University for Continuing Education Krems, Krems, Austria
2 shared publications - Amin Shavandi
Université Libre de Bruxelles (ULB), École Polytechnique de Bruxelles, 3BIO-BioMatter, Avenue F.D. Roosevelt, 50-CP 165/61, B-1050 Brussels, Belgium
2 shared publications - Christoph Bauer
Center for Regenerative Medicine, Department for Health Sciences, Medicine and Research, University for Continuing Education, 3500 Krems, Austria
2 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Photocrosslinkable Silk Fibroin-Hyaluronic Acid Hybrid Hydrogels Enable Chondrocyte-Driven Matrix Deposition and Mechanical Maturation for Cartilage Tissue Engineering
Articular cartilage has limited self-repair capacity, and current treatments fail to fully restore its structure and function. 3D hydrogels that support chondrocyte viability and extracellular matrix (ECM) deposition offer a promising strategy for cartilage regeneration. Here, we developed a photo-crosslinkable silk fibroin–hyaluronic acid hydrogel for 3D encapsulation of primary human chondrocytes. Hydrogels were formulated with varying silk fibroin methacrylate (SilMA, 10-20% w/v) and hyaluronic acid methacrylate (HAMA, 1-2% w/v) concentrations and characterized for rheological, mechanical, and morphological properties. All SilMA-HAMA hydrogel formulations exhibited shear-thinning behavior and rapidly gelled (<20 s) under UV irradiation while maintaining high porosity, thereby ensuring injectability and efficient nutrient diffusion. Notably, the Young’s modulus of the cell-laden scaffolds increased from ~18 kPa to ~1200 kPa over culture, indicating mechanical maturation driven by chondrocyte-mediated matrix deposition. This maturation was further confirmed by histological analysis and qPCR, which demonstrated enhanced ECM production and chondrogenic gene expression. Taken together, these results highlight SilMA-HAMA hydrogels as a promising biomimetic platform that couples mechanical reinforcement with biological functionality for cartilage tissue engineering.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPhotocrosslinkable Silk Fibroin-Hyaluronic Acid Hybrid Hydrogels Enable Chondrocyte-Driven Matrix Deposition and Mechanical Maturation for Cartilage Tissue Engineering
Articular cartilage has limited self-repair capacity, and current treatments fail to fully restore its structure and function. 3D hydrogels that support chondrocyte viability and extracellular matrix (ECM) deposition offer a promising strategy for cartilage regeneration. Here, we developed a photo-crosslinkable silk fibroin–hyaluronic acid hydrogel for 3D encapsulation of primary human chondrocytes. Hydrogels were formulated with varying silk fibroin methacrylate (SilMA, 10-20% w/v) and hyaluronic acid methacrylate (HAMA, 1-2% w/v) concentrations and characterized for rheological, mechanical, and morphological properties. All SilMA-HAMA hydrogel formulations exhibited shear-thinning behavior and rapidly gelled (<20 s) under UV irradiation while maintaining high porosity, thereby ensuring injectability and efficient nutrient diffusion. Notably, the Young’s modulus of the cell-laden scaffolds increased from ~18 kPa to ~1200 kPa over culture, indicating mechanical maturation driven by chondrocyte-mediated matrix deposition. This maturation was further confirmed by histological analysis and qPCR, which demonstrated enhanced ECM production and chondrogenic gene expression. Taken together, these results highlight SilMA-HAMA hydrogels as a promising biomimetic platform that couples mechanical reinforcement with biological functionality for cartilage tissue engineering.
- Open Access
- 20 July 2026
- Published by Elsevier in Materials Today Chemistry
- Vol. 56
Photocrosslinkable silk fibroin-hyaluronic acid hybrid hydrogels enable chondrocyte-driven matrix deposition and mechanical maturation for cartilage tissue engineering
- 20 July 2026
- Published by Elsevier in Materials Today Chemistry
- Vol. 56
Open AccessPhotocrosslinkable silk fibroin-hyaluronic acid hybrid hydrogels enable chondrocyte-driven matrix deposition and mechanical maturation for cartilage tissue engineering
- Open Access
Photocrosslinkable silk fibroin-hyaluronic acid hybrid hydrogels enable chondrocyte-driven matrix deposition and mechanical maturation for cartilage tissue engineering
Articular cartilage has limited self-repair capacity, and current treatments fail to fully restore its structure and function. 3D hydrogels that support chondrocyte viability and extracellular matrix (ECM) deposition offer a promising strategy for cartilage regeneration. Here, we developed a photo-crosslinkable silk fibroin–hyaluronic acid hydrogel for 3D encapsulation of primary human chondrocytes. Hydrogels were formulated with varying silk fibroin methacrylate (SilMA, 10-20% w/v) and hyaluronic acid methacrylate (HAMA, 1-2% w/v) concentrations and characterized for rheological, mechanical, and morphological properties. All SilMA-HAMA hydrogel formulations exhibited shear-thinning behavior and rapidly gelled (<20 s) under UV irradiation while maintaining high porosity, thereby ensuring injectability and efficient nutrient diffusion. Notably, the Young’s modulus of the cell-laden scaffolds increased from ∼18 kPa to ∼1200 kPa over culture, indicating mechanical maturation driven by chondrocyte-mediated matrix deposition. This maturation was further confirmed by histological analysis and qPCR, which demonstrated enhanced ECM production and chondrogenic gene expression. Taken together, these results highlight SilMA-HAMA hydrogels as a promising biomimetic platform that couples mechanical reinforcement with biological functionality for cartilage tissue engineering.
Open AccessPhotocrosslinkable silk fibroin-hyaluronic acid hybrid hydrogels enable chondrocyte-driven matrix deposition and mechanical maturation for cartilage tissue engineering
Articular cartilage has limited self-repair capacity, and current treatments fail to fully restore its structure and function. 3D hydrogels that support chondrocyte viability and extracellular matrix (ECM) deposition offer a promising strategy for cartilage regeneration. Here, we developed a photo-crosslinkable silk fibroin–hyaluronic acid hydrogel for 3D encapsulation of primary human chondrocytes. Hydrogels were formulated with varying silk fibroin methacrylate (SilMA, 10-20% w/v) and hyaluronic acid methacrylate (HAMA, 1-2% w/v) concentrations and characterized for rheological, mechanical, and morphological properties. All SilMA-HAMA hydrogel formulations exhibited shear-thinning behavior and rapidly gelled (<20 s) under UV irradiation while maintaining high porosity, thereby ensuring injectability and efficient nutrient diffusion. Notably, the Young’s modulus of the cell-laden scaffolds increased from ∼18 kPa to ∼1200 kPa over culture, indicating mechanical maturation driven by chondrocyte-mediated matrix deposition. This maturation was further confirmed by histological analysis and qPCR, which demonstrated enhanced ECM production and chondrogenic gene expression. Taken together, these results highlight SilMA-HAMA hydrogels as a promising biomimetic platform that couples mechanical reinforcement with biological functionality for cartilage tissue engineering.
- Open Access
- 21 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Cyclodextrin-epichlorohydrin-cyanoguanidine polymer for resveratrol delivery to enhance human chondrocyte function in cartilage repair
Water-soluble β-cyclodextrin-epichlorohydrin polymers (CDP) are widely utilized for molecular encapsulation, drug delivery, and regenerative medicine. In this work, we present the synthesis of a novel polymer of this family, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC). The primary objective was to evaluate its potential as an efficient carrier for the encapsulation of resveratrol (RES), with a particular focus on applications in cartilage repair. CDPC was synthesized by reacting β-cyclodextrin (β-CD) with epichlorohydrin in the presence of cyanoguanidine (CyG), a nitrogen-rich compound that remains non-protonated under physiological pH. The incorporation of CyG into the polymer network was tuned by adjusting CyG to β-CD molar ratio. Structural characterization of the CDPC was performed using a combination of analytical techniques, including 1H NMR, 13C NMR, HSQC, DOSY NMR, FT-IR, and CHN elemental analysis. Compared to CDP, CDPC exhibited improved RES encapsulation efficiency, as demonstrated by phase solubility and encapsulation studies. The enhanced encapsulation is attributed to additional intramolecular interactions provided by CyG moieties. Dynamic light scattering revealed nanoscale polymer-RES complexes with average sizes of 4 nm for CDP/RES and 18 nm for CDPC/RES, while zeta potential values indicated that these complexes are neutral to slightly negatively charged. CDPC demonstrated intrinsic antioxidant activity, further enhanced upon RES encapsulation. Cytocompatibility assays confirmed that both CDP and CDPC were non-toxic to human chondrocytes. Confocal microscopy of FITC-labeled CDP and CDPC demonstrated effective internalization of these polymers by chondrocytes. Moreover, the CDP/RES and CDPC/RES complexes enhanced chondrocyte metabolic activity and extracellular matrix deposition, demonstrating their potential as carriers for drug delivery in cartilage tissue regeneration.
- 21 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCyclodextrin-epichlorohydrin-cyanoguanidine polymer for resveratrol delivery to enhance human chondrocyte function in cartilage repair
Water-soluble β-cyclodextrin-epichlorohydrin polymers (CDP) are widely utilized for molecular encapsulation, drug delivery, and regenerative medicine. In this work, we present the synthesis of a novel polymer of this family, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC). The primary objective was to evaluate its potential as an efficient carrier for the encapsulation of resveratrol (RES), with a particular focus on applications in cartilage repair. CDPC was synthesized by reacting β-cyclodextrin (β-CD) with epichlorohydrin in the presence of cyanoguanidine (CyG), a nitrogen-rich compound that remains non-protonated under physiological pH. The incorporation of CyG into the polymer network was tuned by adjusting CyG to β-CD molar ratio. Structural characterization of the CDPC was performed using a combination of analytical techniques, including 1H NMR, 13C NMR, HSQC, DOSY NMR, FT-IR, and CHN elemental analysis. Compared to CDP, CDPC exhibited improved RES encapsulation efficiency, as demonstrated by phase solubility and encapsulation studies. The enhanced encapsulation is attributed to additional intramolecular interactions provided by CyG moieties. Dynamic light scattering revealed nanoscale polymer-RES complexes with average sizes of 4 nm for CDP/RES and 18 nm for CDPC/RES, while zeta potential values indicated that these complexes are neutral to slightly negatively charged. CDPC demonstrated intrinsic antioxidant activity, further enhanced upon RES encapsulation. Cytocompatibility assays confirmed that both CDP and CDPC were non-toxic to human chondrocytes. Confocal microscopy of FITC-labeled CDP and CDPC demonstrated effective internalization of these polymers by chondrocytes. Moreover, the CDP/RES and CDPC/RES complexes enhanced chondrocyte metabolic activity and extracellular matrix deposition, demonstrating their potential as carriers for drug delivery in cartilage tissue regeneration.